UCB S.A./ BE0003739530 /
| 05/07/2024 16:49:48 | Chg. +1.5500 | Volume | Bid21:59:59 | Ask21:59:59 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 143.3000EUR | +1.09% | 97 Turnover: 13,919.3500 |
-Bid Size: - | -Ask Size: - | 27.13 bill.EUR | 0.95% | 78.90 |
GlobeNewswire
28/06
United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire
04/06
Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire
04/06
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire
03/06
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire
09/05
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
01/05
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
30/04
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
15/04
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire
01/04
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
25/03
Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire
05/03
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire
05/03
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire
28/02
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire
16/02
United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire
08/02
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire
22/01
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire
15/01
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire
07/01
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...
GlobeNewswire
08/12/2023
General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs
GlobeNewswire
14/11/2023
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
GlobeNewswire
14/11/2023
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
13/11/2023
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanom...
